Malcova

Malcova is a privately held company based in Baltimore, Maryland, specializing in the development of innovative breast cancer healthcare technologies. With a small team of three employees, Malcova has generated $2.5 million in revenue. The company is dedicated to improving health outcomes for women by creating personalized treatments tailored to their individual needs. Malcova focuses on research and development of new medical devices and technologies aimed at enhancing breast cancer healthcare. Through collaborations with leading medical institutions and research-based universities, the company leverages the expertise of a dedicated team to innovate upon existing treatments and develop cutting-edge solutions. The company's ultimate goal is to advance women's health through its groundbreaking work in breast cancer care. Malcova distinguishes itself through its patient-centric approach, recognizing that each woman's healthcare needs are unique. The company prioritizes personalized treatments and leverages collaborative partnerships to ensure its innovations are based on the latest research and clinical expertise. For more information about Malcova and its innovative breast cancer healthcare technologies, please visit malcova.com.